We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Midthun Named Permanent CBER Head, Biologics Safety Effort Launched
Midthun Named Permanent CBER Head, Biologics Safety Effort Launched
October 29, 2010
Karen Midthun has been named the permanent director of CBER and will lead the center as it launches a new effort to improve the safety of biologics and plays a key role in developing a new regulatory path for biosimilars.